MedPath
FDA Approval

Neo-Synalar

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
January 10, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Neomycin(3.5 mg in 1 g)
Fluocinolone acetonide(0.25 mg in 1 g)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Ferndale Laboratories

Medimetriks Pharmaceuticals

005320536

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Neo-Synalar

Product Details

NDC Product Code
43538-940
Application Number
ANDA060700
Marketing Category
ANDA (C73584)
Route of Administration
TOPICAL
Effective Date
January 10, 2023
NeomycinActive
Code: 057Y626693Class: ACTIMQuantity: 3.5 mg in 1 g
Code: 0CD5FD6S2MClass: ACTIBQuantity: 0.25 mg in 1 g
cetyl alcoholInactive
Code: 936JST6JCNClass: IACT
butylated hydroxytolueneInactive
Code: 1P9D0Z171KClass: IACT
citric acid monohydrateInactive
Code: 2968PHW8QPClass: IACT
edetate disodiumInactive
Code: 7FLD91C86KClass: IACT
propylparabenInactive
Code: Z8IX2SC1OHClass: IACT
methylparabenInactive
Code: A2I8C7HI9TClass: IACT
polyoxyl 20 cetostearyl etherInactive
Code: YRC528SWUYClass: IACT
propylene glycolInactive
Code: 6DC9Q167V3Class: IACT
mineral oilInactive
Code: T5L8T28FGPClass: IACT
stearyl alcoholInactive
Code: 2KR89I4H1YClass: IACT
waterInactive
Code: 059QF0KO0RClass: IACT
white waxInactive
Code: 7G1J5DA97FClass: IACT
© Copyright 2025. All Rights Reserved by MedPath